St Mary Medical Center
Long Beach, California, United States
Hospital in Long Beach, California
1050 Linden Ave, Long Beach, CA 90813
415 Beds
About St Mary Medical Center
St. Mary Medical Center is a hospital in Long Beach, California, US. It is currently operated by Dignity Health. SMMC has all private acute care rooms for patients.
There are 415 beds in St Mary Medical Center.
- Top Sponsors
- Top Collaborators
- Trials By Phase
- Recruitment Status
- Top Conditions
- Intervention Types
- Top Intervention Names
- Trials By Gender
Lead Sponsor
# Trials
Clinical Trials at St Mary Medical Center
During the past decade, St Mary Medical Center conducted 1 clinical trials. In the 10-year time frame, 1 clinical trials started and 2 clinical trials were completed, i.e. on
average, 200% percent of trials that started reached the finish line to date. In the past 5 years, 1 clinical trials started and 1 clinical trials were completed. i.e. 100%
of trials that started reached the finish line.
Trials List
Trail ID
Brief Title
Start Date
Completion Date
Status
Enrollment
Prophylaxis Against Tuberculosis (TB) in Patients With Human Immunodeficiency Virus (HIV) Infection and Confirmed Latent Tuberculous Infection
1997-10-01
Completed
2,000
A Randomized, Double-Blind Study of 566C80 Versus Septra (Sulfamethoxazole/Trimethoprim) for the Treatment of Pneumocystis Carinii Pneumonia in AIDS Patients
Completed
300
A Randomized Prospective Study of Pyrimethamine Therapy for Prevention of Toxoplasmic Encephalitis in HIV-Infected Individuals With Serologic Evidence of Latent Toxoplasma Gondii Infection
1992-03-01
Completed
600
A Randomized, Prospective, Double-Blind Study Comparing Fluconazole With Placebo for Primary and Secondary Prophylaxis of Mucosal Candidiasis in HIV-Infected Women
1995-12-01
Completed
400
A Randomized, Comparative, Prospective Study of Daily Trimethoprim / Sulfamethoxazole (TMS) and Thrice-Weekly TMS for Prophylaxis Against PCP in HIV-Infected Patients
1996-11-01
Completed
2,500
A Study of Psychosocial and Behavioral Determinants of Differential Rates of Participant Compliance in CPCRA Protocols
1994-10-01
1996-09-01
Completed
557
A Prospective Study of Multidrug Resistance and a Pilot Study of the Safety of and Clinical and Microbiologic Response to Levofloxacin in Combination With Other Antimycobacterial Drugs for Treatment of Multidrug-Resistant Pulmonary Tuberculosis (MDRTB) in HIV-Infected Patients.
1998-10-01
Completed
525
Clinical Trials Sponsors and Collaborators
Out of the total clinical trials conducted in "St Mary Medical Center" #1 sponsor was "NSABP Foundation Inc" with 2 trials, followed by "Pfizer" with 2 trials
sponsored, "Alliance for Clinical Trials in Oncology" with 1 trials sponsored, "Gilead Sciences" with 1 trials sponsored and "Hoffmann-La Roche"
with 1 trials sponsored. Other sponsors include -4 different institutions and
companies that sponsored additional 6 trials in total.
In terms of collaborators to trials, out of the total clinical trials conducted in "St Mary Medical Center"
#1 collaborator was "National Cancer Institute (NCI)" with 3 trials as a collaborator, "Agency for Healthcare Research and Quality (AHRQ)" with 1 trials as a collaborator and "NCIC Clinical Trials Group" with 1 trials as a collaborator. Other collaborators include -3 different institutions and companies that were
collaborators in the rest 3 trials.
Clinical Trials Conditions at St Mary Medical Center
According to Clinical.Site data, the most researched conditions in "St Mary Medical Center" are
"Breast Cancer" (2 trials), "HIV Infections" (2 trials), "Colorectal Cancer" (1 trials), "Lupus Erythematosus, Systemic" (1 trials) and "Methicillin-resistant Staphylococcus Aureus" (1 trials). Many other conditions were trialed in "St Mary Medical Center" in a lesser frequency.
Clinical Trials Intervention Types at St Mary Medical Center
Most popular intervention types in "St Mary Medical Center" are "Drug" (5 trials), "Biological" (2 trials), "Behavioral" (1 trials) and "Procedure" (1 trials). Other intervention types were less common.
The name of intervention was led by "Adriamycin" (1 trials), "Cyclophosphamide" (1 trials), "Docetaxel" (1 trials), "Doxorubicin" (1 trials) and "Efavirenz" (1 trials). Other intervention names were less common.
Clinical Trials Genders at St Mary Medical Center
The vast majority of trials in "St Mary Medical Center" are
5 trials for "All" genders and 3 trials for "Female" genders.
Clinical Trials Status at St Mary Medical Center
Currently, there are NaN active trials in "St Mary Medical Center".
undefined are not yet recruiting,
undefined are recruiting,
1 are Active, not recruiting,
and undefined are Enrolling by invitation.
In total, there were 7 completed trials in St Mary Medical Center,
undefined suspended trials,
and undefined terminated clinical trials to date.
Out of the total trials that were conducted in St Mary Medical Center, 0 "Phase 1"
clinical trials were conducted, 2 "Phase 2" clinical
trials and 5 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 0 trials, and there were
also 1 trials that are defined as “Not Applicable".